Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone replacement therapy in HIV illness

J G Rabkin1, R Rabkin, G Wagner

  • 1New York State Psychiatric Institute, NY 10032, USA.

General Hospital Psychiatry
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Reactions of 4-oxo-4H-pyrido(3',2':4,5)thieno(3,2-d)-1,3-oxazines with amines].

Die Pharmazie·1992
Same author

[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)amidines by means of reaction of 4-oxo-4H-pyrido(3',2':4,5)thieno(3,2-d)-1,3-oxazines with primary aliphatic amines].

Die Pharmazie·1992
Same author

Effects of DNA binding and metal substitution on the dynamics of the GAL4 DNA-binding domain as studied by amide proton exchange.

Protein science : a publication of the Protein Society·1992
Same author

Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2.

Proceedings of the National Academy of Sciences of the United States of America·1992
Same author

Partial nucleotide sequence of phytochrome from the zygnematophycean green alga Mougeotia.

Photochemistry and photobiology·1992
Same author

[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-amidines by the reaction with 4-oxo-4H-pyrido(3',2':4,5)-thieno(3,2-d)-1,3-oxazines with secondary cycloaliphatic amines].

Die Pharmazie·1992
Same journal

A prospective, randomized exploratory study: Association of preemptive analgesia combined with preoperative transnasal insulin therapy with reduced postoperative delirium in elderly patients undergoing lower extremity fracture surgery.

General hospital psychiatry·2026
Same journal

Short-term ECG safety after inpatient initiation of sertraline versus citalopram or escitalopram: An observational target-trial emulation using MIMIC-IV-ECG.

General hospital psychiatry·2026
Same journal

Patient- and ward-level determinants of psychosomatic-psychiatric consultations for mentally distressed inpatients from medical hospitals: Findings from the SomPsyNet stepped-wedge-trial.

General hospital psychiatry·2026
Same journal

Self-stigma as a central barrier to psychological help-seeking among patients receiving ambulatory Orthopedic care: Paradoxical associations of anxiety and depressive symptoms.

General hospital psychiatry·2026
Same journal

Therapeutic approaches for functional Globus Pharyngeus: A systematic review of studies from 2000 to 2025.

General hospital psychiatry·2026
Same journal

Quetiapine Versus Haloperidol for the Treatment of Delirium in Hospitalized Adults: A Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis.

General hospital psychiatry·2026
See all related articles

Testosterone replacement therapy improved sexual function and mood in HIV+ men with low testosterone and immune suppression. Treatment did not significantly alter CD4 cell counts but offered notable benefits for sexual desire and mood symptoms.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Psychiatry

Background:

  • Human Immunodeficiency Virus (HIV) infection can lead to immune suppression and hormonal imbalances, including low serum testosterone.
  • Low testosterone in HIV+ individuals is associated with sexual dysfunction, mood disturbances, and reduced energy.
  • Understanding the impact of testosterone replacement therapy (TRT) is crucial for managing these comorbidities.

Purpose of the Study:

  • To evaluate the efficacy of TRT in ameliorating sexual dysfunction in HIV+ men.
  • To assess the effects of TRT on mood, energy, and appetite in this population.
  • To determine if TRT impacts immune status, indicated by CD4 cell counts.

Main Methods:

  • A cohort of HIV+ men with low testosterone levels (CD4 < 400 cells/cu mm) received TRT.

Related Experiment Videos

  • Standardized psychiatric assessments, including the Structured Clinical Interview for DSM-III-R and Hamilton Rating Scale for Depression, were used.
  • Sexual function, mood, energy, appetite, and side effects were evaluated at baseline and after 8 weeks of treatment.

    • Main Results:

    • 85% of study completers showed significant improvement in sexual interest and function by week 8.
    • Of those with baseline mood problems, 64% experienced substantial mood improvement.
    • No statistically significant change in mean CD4 cell count was observed post-treatment.

    Conclusions:

    • TRT can be an effective treatment for sexual dysfunction and mood disturbances in HIV+ men with low testosterone and immune suppression.
    • TRT should be considered for managing diminished sexual desire and function in this patient group.
    • Further research with placebo-controlled trials is recommended to confirm these findings.